Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holsboer

Showing results (51-60 of 1,092) with videos related to

Pageof 110
Sort By:
Neuroreport|February 10, 1997
Intact spatial learning and memory in transgenic mice with reduced BDNFA Montkowski, F Holsboer
European Journal of Pharmacology|February 15, 2008
Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonistsFlorian Holsboer, Marcus Ising
Pharmacopsychiatry|August 19, 2024
Precision Psychiatry Approach to Treat Depression and Anxiety Targeting the Stress Hormone System - V1b-antagonists as a Case in PointFlorian Holsboer, Marcus Ising
Psychoneuroendocrinology|January 1, 1986
Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisolA Gerken, F Holsboer
Der Nervenarzt|January 1, 1985
[Neuroendocrinologic and endocrinologic research in depressive patients]F Holsboer, O Benkert
Biological Psychiatry|November 14, 1997
The effect of repeated human corticotropin-releasing hormone administration on dexamethasone-suppressed pituitary-adrenocortical activity in healthy subjectsK Wiedemann, F Holsboer
Nature Reviews. Drug Discovery|May 19, 2012
Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?Guy Griebel, Florian Holsboer
Fortschritte Der Neurologie-Psychiatrie|May 5, 1998
[Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection]C Behl, F Holsboer
Experimental and Clinical Psychopharmacology|January 9, 2008
CRH-sub-1 receptor antagonists for the treatment of depression and anxietyMarcus Ising, Florian Holsboer
Nature|October 12, 2012
Structural biology: Snapshot of an activated peptide receptorFelix Hausch, Florian Holsboer
Pageof 110

Showing results (51-60 of 1,092) with videos related to

Sort By:
Pageof 110
Neuroreport|February 10, 1997
Intact spatial learning and memory in transgenic mice with reduced BDNFA Montkowski, F Holsboer
European Journal of Pharmacology|February 15, 2008
Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonistsFlorian Holsboer, Marcus Ising
Pharmacopsychiatry|August 19, 2024
Precision Psychiatry Approach to Treat Depression and Anxiety Targeting the Stress Hormone System - V1b-antagonists as a Case in PointFlorian Holsboer, Marcus Ising
Psychoneuroendocrinology|January 1, 1986
Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisolA Gerken, F Holsboer
Der Nervenarzt|January 1, 1985
[Neuroendocrinologic and endocrinologic research in depressive patients]F Holsboer, O Benkert
Biological Psychiatry|November 14, 1997
The effect of repeated human corticotropin-releasing hormone administration on dexamethasone-suppressed pituitary-adrenocortical activity in healthy subjectsK Wiedemann, F Holsboer
Nature Reviews. Drug Discovery|May 19, 2012
Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?Guy Griebel, Florian Holsboer
Fortschritte Der Neurologie-Psychiatrie|May 5, 1998
[Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection]C Behl, F Holsboer
Experimental and Clinical Psychopharmacology|January 9, 2008
CRH-sub-1 receptor antagonists for the treatment of depression and anxietyMarcus Ising, Florian Holsboer
Nature|October 12, 2012
Structural biology: Snapshot of an activated peptide receptorFelix Hausch, Florian Holsboer
Pageof 110